ghk-cu copper peptide benefits scientific evidence Peptide: Clinical & Injectable Protocols GHK-CU – Research Peptide |
Description
His factor V activity level was less than 21% and his factor VII level activity was less than 14%
Consider probiotics, digestive enzymes, peptides like BPC-157, and functional medicine testing to identify specific imbalances for personalized treatment
A phase 3 trial called REDEFINE-1 included over 3,400 people who were overweight or obese with one or more comorbidities (like hypertension or cardiovascular disease), but not type 2 diabetes
& Roquilly, A
Development 145 , dev164335 (2018)
